Gene mutation and clonal evolution in patients with myelodysplastic syndromes after treatment of azacitidine / 白血病·淋巴瘤

ABSTRACT

At the 58th American Society of Hematology Annual Meeting,there were many reports on clonal evolution related with blood disease.Gene mutation and clonal evolution after treatment of azacitidine (AZA) in myelodysplastic syndromes (MDS) were summarized to explore the relationship between clonal evolution and treatment response and clinical process in MDS,and to provide reference for clinical treatment decision.